Immatics N.V. (IMTX)
NASDAQ: IMTX · Real-Time Price · USD
9.23
+0.29 (3.24%)
Nov 6, 2025, 4:00 PM EST - Market closed
Immatics Market Cap
Immatics has a market cap or net worth of $1.12 billion as of November 7, 2025. Its market cap has decreased by -1.46% in one year.
Market Cap
1.12B
Enterprise Value
580.51M
1-Year Change
-1.46%
Ranking
Category
Stock Price
$9.23
Market Cap Chart
Since December 12, 2018, Immatics's market cap has increased from $172.50M to $1.12B, an increase of 550.43%. That is a compound annual growth rate of 31.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2025 | 1.12B | 32.21% |
| Dec 31, 2024 | 848.62M | -4.80% |
| Dec 29, 2023 | 891.43M | 34.26% |
| Dec 30, 2022 | 663.94M | -21.47% |
| Dec 31, 2021 | 845.50M | 24.56% |
| Dec 31, 2020 | 678.78M | 263.23% |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 12, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 811.99B |
| Johnson & Johnson | 450.20B |
| AbbVie | 381.38B |
| UnitedHealth Group | 299.68B |
| AstraZeneca | 253.45B |
| Novartis AG | 240.68B |
| Abbott Laboratories | 218.75B |
| Novo Nordisk | 215.64B |